Fat
mass obesity-associated protein (FTO) is a DNA/RNA demethylase
involved in the epigenetic regulation of various genes and is considered
a therapeutic target for obesity, cancer, and neurological disorders.
Here, we aimed to design novel FTO-selective inhibitors by merging
fragments of previously reported FTO inhibitors. Among the synthesized
analogues, compound 11b, which merges key fragments of
Hz (3) and MA (4), inhibited FTO selectively
over alkylation repair homologue 5 (ALKBH5), another DNA/RNA demethylase.
Treatment of acute monocytic leukemia NOMO-1 cells with a prodrug
of 11b decreased the viability of acute monocytic leukemia
cells, increased the level of the FTO substrate N
6-methyladenosine in mRNA, and induced upregulation of MYC and downregulation of RARA, which are
FTO target genes. Thus, Hz (3)/MA (4) hybrid
analogues represent an entry into a new class of FTO-selective inhibitors.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.